Invention Grant
- Patent Title: Method of inhibiting constitutively active phosphorylated FLT3 kinase
-
Application No.: US15715219Application Date: 2017-09-26
-
Publication No.: US10780086B2Publication Date: 2020-09-22
- Inventor: Vinay K. Jain
- Applicant: AROG Pharmaceuticals, Inc.
- Applicant Address: US TX Dallas
- Assignee: AROG PHARMACEUTICALS, INC.
- Current Assignee: AROG PHARMACEUTICALS, INC.
- Current Assignee Address: US TX Dallas
- Agency: Chalker Flores, LLP
- Agent Edwin S. Flores; Daniel J. Chalker
- Main IPC: A61N5/10
- IPC: A61N5/10 ; A61K31/47 ; A61K45/06 ; A61K31/337 ; A61K31/444 ; G01N33/573 ; A61K31/4184 ; A61K31/4709
Abstract:
The present invention includes a method of inhibiting or reducing deregulated FLT3 tyrosine kinase activity or FLT3 tyrosine kinase expression in a subject with a proliferative disease by administering to the subject having or suspected to have the proliferative disease, a therapeutically or prophylactically effective amount of the compound of Formula I: or pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20180055834A1 Method of Inhibiting Constitutively Active Phosphorylated FLT3 Kinase Public/Granted day:2018-03-01
Information query
